Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
复制标题
DOI:
10.1007/s00401-006-0088-2
复制
发表时间:
2006-09-01
影响因子:
12.7
通讯作者:
Attems, Johannes
中科院分区:
文献类型:
--
作者:
Jellinger, Kurt A.;Attems, Johannes
The morphological differentiation of Parkinson disease with dementia (PDD) and dementia with Lewy bodies (DLB) is a matter of discussion. The objective of this study was to investigate the regional distribution of beta-amyloid (A beta) plaques, alpha-synuclein (AS), and pathology in both disorders. The basal ganglia from 17 age-matched patients of PDD and DLB each were immunohistochemically examined with variable degrees of associated Alzheimer pathology using antibodies to A beta, AS, and tau. DLB brains showed a significantly higher burden of (diffuse) amyloid plaques in the putamen and caudate nucleus and slightly more severe tau pathology than PDD brains despite similar neuritic Braak stages. Phases of A beta development in DLB brains often, but inconsistently, correlated with both neuritic Braak stages and severity of striatal A beta load, while these correlations were almost never seen in PDD cases with Alzheimer lesions. They also revealed a higher burden of AS-lesions (both Lewy neurites and Lewy bodies) than PDD cases that commonly had a paucity of all three types of lesion. The globus pallidus was virtually spared in both phenotypes. Differences in AS and A beta pathologies and much less of tau lesions in the striatum support a morphologic distinction between PDD and DLB, which may be of pathophysiologic importance, but the causes of these differences are unclear.